PCAST Members Ready To Speak; President Seems Ready To Listen

Bush has attended each of the White House panel's meetings, raising hopes that PCAST will have an impact on science policy WASHINGTON -- On the job for barely three months, the members of the President's Council of Advisers on Science and Technology are pleased that President Bush has attended at least a portion of each of their meetings. Powerful figures in their own right, they know that direct access to the Oval Office is one important measure of political clout in this city. But the 12 me

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


Bush has attended each of the White House panel's meetings, raising hopes that PCAST will have an impact on science policy
WASHINGTON -- On the job for barely three months, the members of the President's Council of Advisers on Science and Technology are pleased that President Bush has attended at least a portion of each of their meetings. Powerful figures in their own right, they know that direct access to the Oval Office is one important measure of political clout in this city.

But the 12 members of PCAST say that access is not enough. It's the message that matters, they say. And they add that the jury's still out on whether they will actually make a difference in shaping U.S. science and technology policy in the 1990s.

"I don't think that we'll have any problem being heard," says Harold Shapiro, president of Princeton University. "The challenge is to have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jeffrey Mervis

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio